ASM International

26/05/25 -"We have updated our model to take on board the non-cash impairment expense of €215 million that the company accounted for in its Q1 report due to the reduced market valuation of its stake in ASMPT. ..."

PDF page sample
Pages
49
Language
English
Published on
26/05/25
Download
You may also be interested by these reports :
26/05/25
We have updated our model to take on board the non-cash impairment expense of €215 million that the company accounted for in its Q1 report due to the ...
20/05/25
CMD: Lower growth expectations going forward
16/05/25
STMicroelectronics (Add; Netherlands) posted Q1 25 results largely in line with consensus expectations. The book-to-bill ratio being above 1 for both ...
08/05/25
Arm posted positive Q4 25 results, but Q1 26 guidance was weaker than expected, impacting the share price. The company also refrained from providing ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO